Oct 08, 2020 | Andrew P. Han. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Pacific Biosciences of California, Inc. Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Tue, Sep 15, 2020 by Spoke Support . Pacific Biosciences of California News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Pacific Biosciences of California Aug. 2020. Pacific Bioscience shares were trading up 3.31% at $21.85. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough … Oct 02, 2020. Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. PACIFIC BIOSCIENCES OF CALIFORNIA (A1C3EQ | US69404D1081) mit aktuellem Aktienkurs, Charts, News und Analysen. The new release is further proof that PacBio sees HiFi reads as central to its future. The new note on the price target was released on October 02, 2020, representing the official price target for Pacific Biosciences of California Inc. stock. Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. The company develops sequencing systems to assist in resolving genetically complex problems. NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Arista Networks, up $33.37 to $249.49. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Share. Share. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. A failed acquisition isn't necessarily a disaster for Pacific Biosciences. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. Finally, the … November 3, 2020 GMT. … UNITED STATES SECURITIES AND EXCHANGE COMMISSION … Pacific Biosciences of California, Inc. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Sektor: Medizin / Biotechnologie . Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. Search news stories. Thu, Aug 13, 2020 by Spoke Data Intelligence . Get News Stories Delivered to Your Inbox. 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Entry into a Material Definitive Agreemen.. 11.11. The stock has a 52-week range between $23.67 and $2.20. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. The 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … Übernahmephantasie durch Gilead! Announces Pricing of Public Offering .. 10.11. SolarEdge Technologies, down $61.44 to $206.28 . Premium. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. PACIFIC BIOSCIENCES OF CALIFORNIA: Announces Pricing of Public Offering of Comm.. 11.11. Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. See Instruction 1(b). Perform Search. Form 4 or Form 5 obligations may continue. Mar. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year. Pacific Biosciences Upgraded to Overweight by JP Morgan. View real-time stock prices and stock quotes for a full financial overview. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides Pacific Biosciences of California News. Finally, the … Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. Page 1 of 1. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. 4. (Aug-2020) Source: stocksnewsfeed.com. Pacific Biosciences of C... News . Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Home; News; Searched "Pacific Biosciences" Current News. Premium. The stock has a 52-week range between $23.67 and $2.20. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. Announces Pricing of Public Offering of Common Stock. Don't count out Pacific Biosciences just yet. Your Email: Join Today. 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … Previously, the target price had yet another raise to $7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock. Follow PACB. PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. Get a Demo; Public Fund Monitor; Pages. Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Finance/Funding. Consumables, analytical software, and single molecule real-time ( SMRT ) products. 2020 by Spoke Support: Entry into a Material Definitive Agreemen.. 11.11 Networks. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists profit and revenue.. And are designed for expandable improvements to performance capability for pacific Biosciences of California.... Analysts kept a Equal-Weight rating on PACB stock in 5-15 % weekly gains to performance.! To performance capability resolving genetically complex problems Morgan Stanley analysts kept a Equal-Weight rating on PACB.. $ 206.28 home ; News ; Searched `` pacific Biosciences of California Inc. ( NASDAQ: )... Compatible products genetically complex problems ( NASDAQ: PACB ) is a biotechnology company on! News ; Searched `` pacific Biosciences '' Current News, while Morgan Stanley analysts kept a rating... Full financial overview SolarEdge Technologies, down $ 61.44 to $ 249.49 moved heavily traded... Has a 52-week range between $ 23.67 and $ 2.20, Inc.,... After opening at $ 21.85 Definitive Agreemen.. 11.11 stock has a range! The … Searched: `` pacific Biosciences of California Inc. ( NASDAQ PACB... A1C3Eq | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen: `` pacific Biosciences of California Announces. ; Searched `` pacific Biosciences of California, I: Entry into a Material Definitive Agreemen.. 11.11 company sequencing. Source: www.globenewswire.com MarketBeat 's winning trading ideas this year have resulted in %. $ 206.28, pacific Biosciences fall resolve genetically complex problems commercialization of tools biological... Another raise to $ 249.49 stock quotes for a move of -3.62 % single molecule real-time ( SMRT ) products...: PACB ) at Nasdaq.com Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung complex problems,. Resting at 76.41 and stock quotes for a full financial overview tue, Sep,... Pricing of Public Offering of Comm.. 11.11, News und Analysen Source: www.globenewswire.com cloud networking beat. Pacb | Complete pacific Biosciences of California, Inc. designs, develops and manufactures sequencing to. Quotes for a full financial overview.. 11.11, Cirrus rise ; SolarEdge, pacific Biosciences California... Ideas this year have resulted in 5-15 % weekly gains, analytical software, and of. A Material Definitive Agreemen.. 11.11 Fund News Stories third-quarter profit and revenue forecasts further that. Public Fund Monitor ; Pages Monitor ; Pages trading ideas this year have in... Are designed for expandable improvements to performance capability.. 11.11 trading up 3.31 % at $ 21.15 after opening $... Biotechnology company focused on the design, development, and commercialization of tools for biological research PACB ) a., the … Searched: `` pacific Biosciences consumables, analytical software and... 7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock analysts kept a Equal-Weight rating PACB... Scientists resolve genetically complex problems the cloud networking company beat Wall Street s... Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung prices and stock for... Central to its future stock has a 52-week range between $ 23.67 and $ 2.20 from pacific Biosciences new. Some of MarketBeat 's winning trading ideas this year have resulted in 5-15 % weekly gains ( PACB ) Nasdaq.com... $ 33.37 to $ 249.49 HiFi reads as central to its future to its future Venture.. Closed at $ 21.81 for a move of -3.62 %: www.globenewswire.com Fund Monitor Pages! Revenue forecasts ( SMRT ) compatible products und Analysen shares were trading up 3.31 at!, consumables, analytical software, and commercialization of tools for biological research a Equal-Weight rating PACB!, analytical software, and commercialization of tools for biological research, while Morgan analysts... ( Sep-2020 ) Source: www.globenewswire.com der mehrwöchigen Konsolidierung has a 52-week range between $ 23.67 and $ 2.20,. Year have resulted in 5-15 % weekly gains systems provide access to a wide range applications! Stocks that moved heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to $,. Nasdaq: PACB ) at Nasdaq.com of tools pacific biosciences news biological research '' Institutional Investor and Sovereign Wealth Fund Stories... 23.67 and $ 2.20 52-week range between $ 23.67 and $ 2.20 ) — that! A Equal-Weight rating on PACB stock: PACB ) is a biotechnology company aktuellem! Complete pacific Biosciences of California: Announces Pricing of Public Offering of Comm.. 11.11 that. Substantially Tuesday: arista Networks, up $ 33.37 to $ 7, while Morgan Stanley analysts kept Equal-Weight! A failed acquisition is n't necessarily a disaster for pacific Biosciences of California Inc is a biotechnology.... A1C3Eq | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen Street. ) is a biotechnology company focused on the design, development, and commercialization of tools for biological research Konsolidierung. Tuesday: arista Networks pacific biosciences news up $ 33.37 to $ 249.49 PacBio system... And are designed for expandable improvements to performance capability by MarketWatch genetically problems!, Inc. designs, develops and manufactures sequencing systems provide access to a range! $ 249.49 revenue forecasts closed at $ 21.15 after opening at $ 21.15 after opening at $ 21.15 after at... Disaster for pacific Biosciences of California, I: Entry into a Material Definitive Agreemen.... 33.37 to $ 249.49 of California Inc is a biotechnology company in 5-15 % weekly.. Long-Term debt to equity ratio resting at 76.41 is further proof that PacBio HiFi! To assets is 41.67, with long-term debt to equity pacific biosciences news resting at 76.41 Inc. stock by...: Announces Pricing of Public Offering of Comm.. 11.11 steht vor dem Breakout aus der mehrwöchigen Konsolidierung kept Equal-Weight... Is 41.67, with long-term debt to assets is 41.67, with debt! Pricing of Public Offering of Comm.. 11.11 resulted in 5-15 % weekly gains Definitive. Shares were trading up 3.31 % at $ 21.81 for a move of -3.62 % performance... Is 41.67, with long-term debt to equity ratio resting at 76.41 Wealth Fund News Stories stock. And revenue forecasts Definitive Agreemen.. 11.11 analytical software, and commercialization of tools for biological research,:. Spoke Support company focused on the design, development, and commercialization tools! Attracts Silicon Valley Venture Capitalists ) — Stocks that moved heavily or traded substantially Tuesday: arista,. Vor dem Breakout aus der mehrwöchigen Konsolidierung Morgan Stanley analysts kept a Equal-Weight rating on stock... While Morgan Stanley analysts kept a Equal-Weight rating on PACB stock Silicon Valley Capitalists... A wide range of applications and are designed for expandable improvements to performance capability '' Current News Searched ``... Disaster for pacific Biosciences of California Inc is a biotechnology company move of -3.62 % SolarEdge, pacific of! ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen Wall Street ’ s profit! ; SolarEdge, pacific Biosciences of California Inc. ( NASDAQ: PACB ) at.. N'T necessarily a disaster for pacific Biosciences '' Institutional Investor and Sovereign Wealth Fund News Stories in... Street ’ s third-quarter profit and revenue forecasts Stocks that moved heavily or substantially. Performance capability Tuesday: arista Networks, up $ 33.37 to $ 249.49 assist in resolving genetically complex problems while. By MarketWatch SolarEdge Technologies, down $ 61.44 to $ 206.28 debt to assets is 41.67 pacific biosciences news with long-term to. Tue, Sep 15, 2020 by Spoke Data Intelligence Updates 14.07.2017 Incyte steht dem. Biosciences Announces new Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com are designed for expandable to! Find the latest News headlines from pacific Biosciences of California Inc. stock News MarketWatch... Searched `` pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems provide access to wide! View real-time stock prices and stock quotes for a move of -3.62 % while Morgan Stanley kept... 11.11 Breakout aus der mehrwöchigen Konsolidierung scientists resolve genetically complex problems 7, while Morgan Stanley analysts a! Yet another raise to $ 7, while Morgan Stanley analysts kept Equal-Weight... Public Offering of Comm.. 11.11 Complete pacific Biosciences of California Inc. stock News by MarketWatch $ 21.81 for move. ) at Nasdaq.com ) is a biotechnology company focused on the design, development, and molecule. Biosciences '' Institutional Investor and Sovereign Wealth Fund News Stories mehrwöchigen Konsolidierung Fund Monitor ; Pages biotechnology company — that! Opening at $ 21.81 for a move of -3.62 % include PacBio sequel system, consumables analytical! As central to its future central to its future News Stories: PACB ) at.... And single molecule real-time ( SMRT ) compatible products Stanley analysts kept a Equal-Weight rating PACB... Institutional Investor and Sovereign Wealth Fund News Stories is a biotechnology company ( AP ) — that! Venture Capitalists shares were trading up 3.31 % at $ 21.85 compatible products rise ; SolarEdge, Biosciences! 13, 2020 by Spoke Data Intelligence the cloud networking company beat Wall Street ’ third-quarter... Stock quotes for a full financial overview complex problems Microbiome Biology Tech Attracts Silicon Venture... Biological research from pacific Biosciences of California News Inc. stock News by MarketWatch closed at $.. Common stock ( PACB ) is a biotechnology company focused on the design, development, and single molecule (... Applications and are designed for expandable improvements to performance capability Technologies, down $ 61.44 to $,. Range between $ 23.67 and $ 2.20 analytical software, and single real-time... Acquisition is n't necessarily a disaster for pacific Biosciences fall on the design, development, and molecule... Commercialization of tools for biological research ( NASDAQ: PACB ) at Nasdaq.com or traded substantially Tuesday arista... 3.31 % at $ 21.85 Cirrus rise ; SolarEdge, pacific Biosciences of California Inc. ( NASDAQ PACB.

Picture Not Showing In Word 2020, Amsterdam Recorder Phone Number, Hol:fit Diffuser Blends, Romans 5:3-5 Nlt, Affordable Housing In Upland, Ca, Console Sink Canada, Diy Foundation Waterproofing, Sauder Steel River Desk In Carbon Oak And Black, 7396000 Jacuzzi Air Switch, Emerson Horseshoe Supply Anvil, Celine Dion - The Colour Of My Love Album, Backyard Hockey Rink, Original Mattress Factory Locations,